Your fact-checks will appear here
Female given name
Continuous glucose monitors (CGMs) and newer glucose-lowering agents such as GLP‑1 receptor agonists and SGLT2 inhibitors promise better outcomes, but their uptake in underserved populations is constr...
Available sources show no peer-reviewed clinical trials or FDA registrations proving SugarWise (the supplement marketed as for “glucose control”) is effective for diabetes; promotional sites claim ing...
The marketing for Sugar Control™ positions it as a natural supplement intended to "support" balanced blood glucose and metabolic wellness, not as a replacement for medication or medical care . Peer-re...
Guidelines converge on a risk‑based, not purely glycemia‑based, choice: SGLT2 inhibitors are recommended for cardiorenal protection down to low eGFR thresholds (often ≥20 mL/min/1.73 m2) despite reduc...
Home-based programs—ranging from telemedicine-supported lifestyle coaching to virtual community weight-management and self-administered behavioral protocols—are supported by randomized trials and pilo...
Consumers comparing supplement claims about A1C changes to prescription diabetes drugs must weigh modest, variable trial results for some supplements against large, well-controlled trials showing clin...
Federal law enforcement agencies do not share a single, statutory minimum psychological-evaluation standard; requirements vary by agency and many federal components lack routine pre-employment psychol...
By 2025, several new small-molecule oral GLP‑1 candidates (notably orforglipron) and multiple biologic GLP‑1/GIP agonists and biosimilar insulins were in wide clinical use or newly approved; real-worl...
See a clinician promptly if you have severe pain, fever, spreading redness, pus, or uncontrolled bleeding; most simple anal fissures heal with conservative care but complications (abscess, fistula, pe...
SugarWise is marketed as a natural dietary supplement “suitable for anyone looking to support blood sugar management, particularly those with pre‑diabetes or diabetes” and the company repeatedly warns...
Since 2020, reporting and research highlight several major advances in type 2 diabetes (T2D) care: approval and wider adoption of GLP‑1 receptor agonists including an oral GLP‑1, emergence of dual‑ago...
Federal hiring law protects applicants with HIV from pre-offer disability inquiries and unlawful discrimination, and requires confidentiality and reasonable accommodations once a conditional offer is ...